multiple sclerosis

News

Regulators finally back Merck KGaA oral MS drug

A long-awaited oral multiple sclerosis drug from Merck KGaA was among a raft of medicines given the green light by Europe's regulator on Friday.

News

Brain infection would be bad news for Roche's MS drug Ocrevu...

Suggestion is that PML case was caused by previous treatment.

News

Celgene MS pill can't beat older rival on disability progres...

Phase 3 trial meets main efficacy endpoint, but disability progression stats cause concern.

News

Laquinimod failure is bad news for Teva's MS hopes

Teva has been forced to abandon laquinimod in relapsing-remitting multiple sclerosis, after it missed a target related to disability progression in a late stage trial.

News

Biogen shares up after strong launch for rare disease drug

US insurers are covering the treatment, despite high price.

News

Will Gottlieb follow up on Trump's promise of a bonfire of regulations?

FDA approves two biggest new drugs of 2017

Sales of MS and eczema drugs could top $4bn by 2022

Regulators finally back Merck KGaA oral MS drug

Brain infection would be bad news for Roche's MS drug Ocrevu...

Celgene MS pill can't beat older rival on disability progres...

Laquinimod failure is bad news for Teva's MS hopes

Biogen shares up after strong launch for rare disease drug

FDA approves two biggest new drugs of 2017

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

multiple sclerosis

Editor's Picks